You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

almorexant

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety, Tolerability, Pharmacodynamics Trial in Leiden (ACT-462206 5 mg, ACT-462206 25 mg, ACT-462206 100mg)

Completed
  • Safety
  • +3 more
  • ACT-462206 5 mg
  • +8 more
  • Leiden, Netherlands
    Centre for Human Drug Research
Jul 6, 2018

Restless Legs Syndrome Trial in Madrid (Suvorexant, Placebo)

Unknown status
  • Restless Legs Syndrome
  • Madrid, Spain
    Sleep Research Institute; Paseo de la Habana 151
Nov 27, 2018

Abuse Potential Study Trial (200 mg almorexant, 400 mg almorexant, 1000 mg almorexant)

Completed
  • Abuse Potential Study
  • 200 mg almorexant
  • +5 more
  • (no location specified)
Feb 11, 2016

Insomnia, Primary Insomnia Trial in Worldwide (almorexant)

Completed
  • Insomnia
  • Primary Insomnia
  • almorexant
  • Innsbruck, Austria
  • +26 more
Feb 11, 2016

Primary Insomnia Trial in Worldwide (almorexant, Placebo, zolpidem)

Completed
Has Results
  • Primary Insomnia
  • almorexant
  • +2 more
  • Adelaide, South Australia, Australia
  • +90 more
Feb 11, 2016

Chronic Primary Insomnia Trial in United States (ACT-078573 oral capsules at 25 and 100 mg and matching , ACT-078573 and

Completed
Has Results
  • Chronic Primary Insomnia
  • ACT-078573 oral capsules at 25 and 100 mg and matching placebo
  • ACT-078573 and matching placebo
  • Hot Springs, Arkansas
  • +20 more
Feb 11, 2016

Healthy Volunteers Trial in San Francisco (Almorexant, Zolpidem 10mg, Placebo)

Completed
  • Healthy Volunteers
  • Almorexant
  • +2 more
  • San Francisco, California
    San Francisco Veterans Affairs Medical Center
Oct 2, 2014